Probing Intercellular heterogeneity in Circulating TUmor cells of de novo metastatic Hormone Sensitive Prostate CanceR patiEntS (PICTURES)

Early identification of metastatic prostate cancer patients that will develop resistance to androgen deprivation therapy will provide the opportunity to switch to a more effective treatment early on. In PICTURES technology will be developed that will not only identify such patients but also provides the information needed to predict the most appropriate therapy.

  • Projectnummer / Project number: 17915
  • Deelnemende kennisinstellingen / Participating institutes: ErasmusMC
  • Gebruikers / Users: 2 bedrijven, 2 organisaties en 1 ander ziekenhuis / 2 companies, 2 organisations and 1 other hospital
  • Projectleider / Project leader: Prof.dr. L.W.M.M. Terstappen, Universiteit Twente
  • Type project / Type project: Lopend
  • Startdatum / Start date: 1-01-2020
  • Einddatum / End date: 1-01-2024
  • Programma / Programme: Partnership NWO-domein TTW-KWF Kankerbestrijding-Topsector Life Science & Health: Technology for Oncology II
  • Vakgebied / Discipline: Levenswetenschappen / Life sciences


Contact

Drs. Marjolein van Dalen (Programmamedewerker) Drs. Marjolein van Dalen (Programmamedewerker) +31 (0)30 6001234 m.vandalen@nwo.nl